For ovarian cancer, who performs the surgery may matter as much as which centre you go to. Cytoreductive surgery outcomes correlate strongly with surgeon training, volume, and team support — measurable differences in survival depending on where this surgery is done.
On this page
Cytoreductive surgery surgeon experience — The Cytoreduction Completeness (CC) score
After surgery, residual disease is measured:
- CC-0: no visible residual disease
- CC-1: residual disease ≤ 2.5mm
- CC-2: residual disease 2.5mm–2.5cm
- CC-3: residual disease > 2.5cm
5-year survival correlates directly: CC-0 patients survive significantly longer than CC-1, who survive significantly longer than CC-2/3. The single most important goal of cytoreductive surgery is to achieve CC-0 or CC-1.
Surgeon volume effect
Multiple peer-reviewed studies show:
- High-volume surgeons (25+ ovarian debulking procedures annually) achieve CC-0/1 in 60–80% of cases
- Low-volume surgeons (under 10/year) achieve CC-0/1 in 30–50% of cases
- The difference translates to 6–12 months of overall survival difference at population level
Centre volume effect
Centre infrastructure matters independent of surgeon volume:
- Multidisciplinary tumour board availability
- Intra-operative imaging and frozen section pathology
- ICU and blood bank capacity
- Trained anaesthesia and perioperative team
- Specialised nursing
A high-volume surgeon at a high-volume centre is the strongest combination.
Questions to ask
- How many ovarian cytoreductive surgeries do YOU personally perform annually?
- What is YOUR CC-0/CC-1 rate?
- What is YOUR 30-day mortality rate?
- What is YOUR major complication rate (Clavien-Dindo Grade III or higher)?
- Where do you publish or share outcomes data?
Surgeons confident in their work answer these questions directly. Evasion is itself an answer.
How to find the right surgeon
- Look for fellowship training specifically in gynaecological oncology
- Check society memberships (ESGO, IGCS, IAGO)
- Look at publications — academic engagement signals ongoing practice refinement
- Ask for case volume directly
- Consider a second opinion before committing
See cytoreductive surgery overview and 9 factors affecting HIPEC success.
FAQs
What if my local hospital does cytoreductive surgery occasionally?
Volume matters. If the centre does less than 10 such cases annually, travelling to a higher-volume centre may significantly improve outcomes. Discussion with referring physician is warranted.
Is centre prestige the same as volume?
No — name-brand hospital ≠ high case volume for your specific procedure. Ask for actual numbers, not branding.
What is Dr. Nishtha's case volume?
Dr. Nishtha is happy to discuss case volume directly during consultation. Annual cytoreductive cases are substantial across Sterling, KD and Welcare combined.
Does laparoscopic cytoreduction work?
Generally no for advanced ovarian cancer. Open surgery is the standard. Selected early-stage disease may be staged minimally invasively.
Why doesn't the chemotherapy compensate for incomplete surgery?
Chemotherapy is most effective against microscopic disease. Visible residual disease (CC-2/3) is much less responsive. This is why surgical completeness matters even when chemo follows.
Consultation and Next Steps
For an individualised consultation on cytoreductive surgery surgeon experience, share your reports on WhatsApp at +91 76988 00333. Dr. Nishtha Tripathi Patel provides a detailed assessment within 24-48 hours and arranges in-person consultation at Sterling Hospitals, KD Hospital, or Welcare Speciality Hospital in Ahmedabad based on your location and treatment requirements.
Bring the following to your first consultation: imaging studies (ultrasound, CT or MRI on CD), histopathology and biopsy reports, tumour marker results (CA-125, HE4, CEA where relevant), a list of current medications, and any prior treatment summaries. For patients travelling from outside Ahmedabad, scheduling can be arranged to complete consultation and any pre-op work-up in the fewest possible visits.
If you are exploring second-opinion options, see our second-opinion service page. Independent review of diagnosis, staging, and proposed treatment plans is provided at no cost via WhatsApp report review. You do not need to switch hospitals to obtain a second opinion.
For broader information about cytoreductive surgery surgeon experience and related conditions, also see our complete ovarian cancer guide, HIPEC India guide, cervical cancer guide and robotic surgery guide.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. To book: WhatsApp +91 76988 00333.